Anika Therapeutics Inc banner

Anika Therapeutics Inc
SWB:AKP

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
SWB:AKP
Watchlist
Price: 13.9 EUR 5.3%
Market Cap: €330.9m

DCF Value

The DCF Value for Anika Therapeutics Inc (AKP) under the Base Case is 13.94 EUR. Compared with the current market price of 13.9 EUR, the stock appears Fairly Valued .

Key assumptions
AKP DCF Value
Base Case
13.94
Fairly Valued
DCF Value
Price €13.9
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time